ipilimumab ^Turanci (Q2459042)

pharmaceutical drug ^Turanci

Language	Label	Description	Also known as
Hausa	Ba suna a kai	Ba'a bayyana ma'ana ba
Turanci	ipilimumab	pharmaceutical drug	MDX-010 MDX-101 MOAB-CTLA-4 MDX-CTLA-4

Statements

iri

type of chemical entity ^Turanci

0 references

Ƙaramin ɓangare na

chemical compound ^Turanci

0 references

amfani

magani

1 reference

laƙabi

Ipilimumab (Turanci)

stated in ^Turanci

DrugBank ^Turanci

harshen aiki ko suna

Turanci

ranar wallafa

17 Nuwamba 2015

DrugBank ID ^Turanci

06186

image of molecular model or crystal lattice model ^Turanci

Ipilimumab 5TRU.png
2,048 × 1,767; 152 KB

depicts ^Turanci

space-filling model ^Turanci

0 references

active ingredient in ^Turanci

Yervoy ^Turanci

1 reference

European Medicines Agency product number ^Turanci

EMEA/H/C/002213

adireshin manazarta

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002213/human_med_001465.jsp

retrieved ^Turanci

22 Maris 2017

World Health Organisation international non-proprietary name ^Turanci

ipilimumab (Turanci)

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

Ipilimumab (Turanci)

retrieved ^Turanci

19 Janairu 2016

medical condition treated ^Turanci

metastatic melanoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

melanoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

renal cell carcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

myelodysplastic syndrome ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

non-small-cell lung carcinoma ^Turanci

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Ciwon daji na fata

1 reference

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

ta jiki ma'amala da

cytotoxic T-lymphocyte associated protein 4 ^Turanci

subject has role ^Turanci

reaction inhibitor ^Turanci

1 reference

stated in ^Turanci

Open Targets Platform ^Turanci

retrieved ^Turanci

14 Agusta 2023

adireshin manazarta

https://platform.opentargets.org/drug/CHEMBL1789844

route of administration ^Turanci

intravenous infusion and defusion ^Turanci

0 references

pregnancy category ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

LiverTox likelihood score ^Turanci

LiverTox toxicity likelihood category A ^Turanci

1 reference

stated in ^Turanci

LiverTox ^Turanci

retrieved ^Turanci

8 Afirilu 2021

adireshin manazarta

https://www.ncbi.nlm.nih.gov/books/n/livertox/Ipilimumab

last update ^Turanci

16 Faburairu 2018

has characteristic ^Turanci

biopharmaceutical ^Turanci

1 reference

laƙabi

Ipilimumab (Turanci)

stated in ^Turanci

DrugBank ^Turanci

harshen aiki ko suna

Turanci

ranar wallafa

17 Nuwamba 2015

DrugBank ID ^Turanci

06186

subject has role ^Turanci

monoclonal antibody ^Turanci

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Ipilimumab (Turanci)

17 Nuwamba 2015

Identifiers

CAS Registry Number ^Turanci

477202-00-9

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Ipilimumab (Turanci)

17 Nuwamba 2015

ChEMBL ID ^Turanci

CHEMBL1789844

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

Ipilimumab (Turanci)

retrieved ^Turanci

19 Janairu 2016

LiverTox ID ^Turanci

Ipilimumab

0 references

Lambar ATC

L01XC11

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Ipilimumab (Turanci)

17 Nuwamba 2015

Guide to Pharmacology Ligand ID ^Turanci

6888

0 references

MeSH descriptor ID ^Turanci

D000074324

subject named as ^Turanci

Ipilimumab

0 references

Lambar itace MeSH

D12.776.124.486.485.114.224.060.798

0 references

D12.776.124.790.651.114.224.060.798

0 references

D12.776.377.715.548.114.224.200.798

0 references

RxNorm ID ^Turanci

1094833

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000182641

retrieved ^Turanci

26 Faburairu 2018

DrugBank ID ^Turanci

DB06186

0 references

UNII ^Turanci

6T8C155666

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

IPILIMUMAB (Turanci)

retrieved ^Turanci

19 Janairu 2016

MedlinePlus drug identifier ^Turanci

a611023

0 references

NDF-RT ID ^Turanci

N0000182641

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

IPILIMUMAB (Turanci)

retrieved ^Turanci

19 Janairu 2016

KEGG ID ^Turanci

D04603

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

Ipilimumab (Turanci)

retrieved ^Turanci

19 Janairu 2016

DeCS ID ^Turanci

57066

0 references

Encyclopædia Britannica Online ID ^Turanci

science/ipilimumab

subject named as ^Turanci

ipilimumab

0 references

Freebase ID ^Turanci

/m/027ywgv

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

ranar wallafa

28 Oktoba 2013

Microsoft Academic ID ^Turanci

2781433595

0 references

OpenAlex ID ^Turanci

C2781433595

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

adireshin manazarta

https://docs.openalex.org/download-snapshot/snapshot-data-format

WikiProjectMed ID ^Turanci

Ipilimumab

0 references

ipilimumab ^Turanci (Q2459042)

Statements

Identifiers

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Wasu shafuka(0 entries)

Kewayawa Menu

ipilimumab Turanci (Q2459042)

Statements

Identifiers

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Wasu shafuka(0 entries)

Kewayawa Menu

Nema

ipilimumab ^Turanci (Q2459042)